COVID vaccine names higher following Moderna second booster request
Morsa Images/DigitalVision via Getty Images


Three companies whose revenue is heavily dependent on COVID-19 vaccines -- Moderna (NASDAQ:MRNA
+3.3%), BioNTech (NASDAQ:BNTX
+4.0%), and Novavax (NASDAQ:NVAX
+4.0%) -- are all trading higher today following Moderna's (MRNA
+3.6%) late Thursday night announcement it has asked the U.S. FDA to authorize a second booster dose for all adults.

Moderna (MRNA
+3.3%) said its authorization is for a wide population to give the CDC and doctors discretion in determining who should get a second booster.
Recall that on Tuesday, Pfizer (PFE
-0.4%) and BioNTech (BNTX
+4.0%) asked the FDA to expand their vaccine authorization for a second booster, but only in adults 65 years and older.